Form D · Other Technology
Fibroblast, Inc.
Chicago, IL · CIK 0001587278
Offering snapshot reported Jan 15, 2020 · SEC filing
- Reported sold
- $500K Offering amount: $1M
- Investors reported
- 1 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Jan 7, 2020 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jan 15, 2020 | Initial | $500,000 | No comparison | 1 | SEC filing |
| Jan 16, 2018 | Initial | $2,000,000 | No comparison | 3 | SEC filing |
| Oct 9, 2013 | Initial | $727,668 | No comparison | 11 | SEC filing |
Offering details
- Securities
- Debt, Option to acquire, Security to be acquired
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-358164
Source: Form D, filed Jan 15, 2020. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Andrew Albert | Executive |
| Eric Alvarez | Executive |
| Christopher Capps | Director |
| Jordan Dolin | Director |
| Kirk Elder | Director |
| Mark Luy | Executive |
| Elias Pearson | Director |
| Scott Vold | Director, Executive |
| Kevin Weinstein | Director |
Issuer details
Industry: Other Technology (See others in industry)
Address:
640 N. La Salle Drive Suite 200
Chicago, IL, 60654
Chicago, IL, 60654